Filing Flows › Comparisons › AGEN vs DNA
Agenus vs Ginkgo Bioworks Holdings: AGEN and DNA compared
Agenus is the larger company: $31.5M of revenue in its latest quarter (Q3 2026) against $20.2M for Ginkgo Bioworks Holdings (Q2 2026). Agenus is growing faster (+4% against -48% a year earlier). Agenus is more profitable, with an operating margin of 36.2% against -290.5%.
Where the money goes: AGEN and DNA
Agenus (AGEN) · Q3 2026
Agenus, Q3 2026: revenue $31.5M (+4% year over year), operating margin 36.2%, net earnings $1.5M, operating cash flow −$20.1M. The chart follows the revenue to costs, profit and cash.
Ginkgo Bioworks Holdings (DNA) · Q2 2026
Ginkgo Bioworks Holdings, Q2 2026: revenue $20.2M (-48% year over year), operating margin -290.5%, net loss $46.7M, operating cash flow −$44.3M. The chart follows the revenue to costs, profit and cash.
| Agenus (AGEN) | Ginkgo Bioworks Holdings (DNA) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $31.5M | $20.2M |
| Revenue growth, Y/Y | +4% | -48% |
| Operating margin | 36.2% | -290.5% |
| Net earnings | $1.5M | −$46.7M |
| Net margin | 4.8% | -231.7% |
| Operating cash flow | −$20.1M | −$44.3M |
Where the revenue comes from
Agenus
- Non Cash Royalty Revenue Related to the Sale of Future Royalties: $25.4M (81%)
- Pre Commercial Product Revenue: $6.1M (19%)
Questions
Which is bigger, Agenus or Ginkgo Bioworks Holdings?
Agenus is the larger company: $31.5M of revenue in its latest quarter (Q3 2026) against $20.2M for Ginkgo Bioworks Holdings (Q2 2026).
Is Agenus or Ginkgo Bioworks Holdings growing faster?
Agenus is growing faster (+4% against -48% a year earlier).
Which is more profitable, Agenus or Ginkgo Bioworks Holdings?
Agenus is more profitable, with an operating margin of 36.2% against -290.5%.
More: Agenus earnings · how Agenus makes money · Ginkgo Bioworks Holdings earnings · how Ginkgo Bioworks Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 6, 2026). Fiscal quarters can end on different dates. Not investment advice.